Reports
Sale
Global in Silico Clinical Trials Market Size, Share, Report: By Industry Type: Medical Devices, Pharmaceuticals; By Therapeutic Area: Oncology, Infectious Disease, Hematology, Cardiology, Dermatology, Neurology, Diabetes, Others; By Phase: Phase I, Phase II, Phase III, Phase IV; Regional Analysis; Supplier Landscape; 2024-2032
Global In Silico Clinical Trials Market Outlook
The global in silico clinical trials market size was valued at USD 3.33 billion in 2023, driven by the rise in demand of personalized medicine across the globe. The market is anticipated to grow at a CAGR of 7.42% during the forecast period of 2024-2032 to achieve a value of USD 6.34 billion by 2032.
In Silico Clinical Trials: Introduction
In silico clinical trials are used to perform tests and trials pre-launch of drugs and medicines in the market. The in silico clinical trials, which are also known as virtual clinical trials, are used to perform clinical tests without harming any human or animal. In these clinical trials computer-based models and simulations are used to know about the safety, accuracy, efficiency and outcomes of the treatment before sending them under real trials. With the help of in silico clinical trials, time consumption in comparison to the real trials is less. In in silico clinical trials, the imitation of real medicines takes place, which is further utilized to personalize treatment process and develop personalize treatment plan. It also helps in speeding up the development process of the drug and the time when it would be active in the body.
Global In Silico Clinical Trials Market Analysis
The increasing focus on potential of in silico clinical trials in the development process of drug as it provides useful insights before the real human trials, is expected to aid the in-silico clinical trials market growth. This process has the potential of reducing the time, expenditure and effectiveness of the drug development process.
Additionally, with the help of in silico clinical trials combined with the patient-specific data, such as medical symptoms from past or genetic data, in order to generate personalized medicine will directly contribute to the market growth. The increasing technological development in the healthcare industry and specifically in in-silico clinical trials has been creating a huge impact on the market as well, propelling the global in-silico clinical trials market expansion. Advanced technologies like artificial intelligence and machine learning are used to perform in-silico clinical trials in order to achieve more accuracy and by processing data which would not be possible to process easily with the use of other traditional methods.
Global In Silico Clinical Trials Market Segmentations
Market Segmentation by Industry
- Medical Devices
- Pharmaceuticals
Market Breakup by Therapeutic Area
- Oncology
- Infectious Disease
- Hematology
- Cardiology
- Dermatology
- Neurology
- Diabetes
- Others
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global In Silico Clinical Trials Market Overview
The major factors driving the market growth include the involvement of advanced technologies such as artificial intelligence and machine learning to achieve more accuracy in the outcomes of these trials. More accuracy will result in the development of more effective drugs and medicines. In-silico clinical trials saves time and are cost-effective as well as they are not being performed on real humans or animals but virtual patients.
Additionally, the continuous development to increase the efficiency of software used in the systems for these trials also contributes to the technological advancement in in-silico clinical trials. The market is growing steadily from past few years and is expected to keep growing steadily in future as well. In silico clinical trials helps researchers to simulate the drug responses in virtual patient populations which further helps in the development of personalized medicine approaches and facilitates the optimization of drug regimens for particular patient populations and improving treatment outcomes further contributing to the global in-silico clinical trials market expansion.
Global in Silico Clinical Trials Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Dassault Systèmes SE
- Certara Inc.
- Insilico Medicine
- GNS Healthcare Inc.
- The AnyLogic Company
- Novadiscovery SAS
- InSilicoTrials Technologies SpA
- Immunetrics Inc.
- CATO SMS
- Evotec SE
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Industry Type |
|
| Breakup by Therapeutic Area |
|
| Breakup by Phase |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global In Silico Clinical Trials Market Overview
3.1 Global In Silico Clinical Trials Market Historical Value (2017-2023)
3.2 Global In Silico Clinical Trials Market Forecast Value (2024-2032)
4 Global In Silico Clinical Trials Market Landscape
4.1 Global In Silico Clinical Trials Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global In Silico Clinical Trials Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indications
4.2.3 Analysis by Phase
5 Global In Silico Clinical Trials Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global In Silico Clinical Trials Market Segmentation
6.1 Global In Silico Clinical Trials Market by Industry Type
6.1.1 Market Overview
6.1.2 Medical Devices
6.1.3 Pharmaceuticals
6.2 Global In Silico Clinical Trials Market by Therapeutic Area
6.2.1 Market Overview
6.2.2 Oncology
6.2.3 Infectious Disease
6.2.4 Hematology
6.2.5 Cardiology
6.2.6 Dermatology
6.2.7 Neurology
6.2.8 Diabetes
6.2.9 Others
6.3 Global In Silico Clinical Trials Market by Phase
6.3.1 Market Overview
6.3.2 Phase I
6.3.3 Phase II
6.3.4 Phase III
6.3.5 Phase IV
6.4 Global In Silico Clinical Trials Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America In Silico Clinical Trials Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe In Silico Clinical Trials Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific In Silico Clinical Trials Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America In Silico Clinical Trials Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa In Silico Clinical Trials Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Dassault Systèmes SE
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Certara Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Insilico Medicine
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 GNS Healthcare Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 The AnyLogic Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Novadiscovery SAS
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 InSilicoTrials Technologies SpA
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Immunetrics Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 CATO SMS
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Evotec SE
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certificationsa
18 Global In Silico Clinical Trials Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 3.33 billion in 2023, driven by the increased integration of advanced technologies in the market.
The market is anticipated to grow at a CAGR of 7.42% during the forecast period of 2024-2032 to reach a market value of USD 6.34 billion by 2032.
The increasing demand for personalized medicine across the globe is among the major drivers for the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The different types of industries in the market include medical devices and pharmaceuticals.
The different therapeutic areas in the market are oncology, infectious disease, hematology, cardiology, dermatology, neurology, and diabetes, among others.
The end users in the market include hospitals and clinics, diagnostic centres, academic research institutions, among others.
The different phases of the trials are Phase I, Phase II, Phase III, and Phase IV.
The adoption of new technologies such as artificial intelligence and machine learning in in-silico clinical trials is among the major key trends in the market.
Key players involved in the market are Dassault Systèmes SE, Certara Inc., Insilico Medicine, GNS Healthcare Inc., The AnyLogic Company, Novadiscovery SAS, InSilicoTrials Technologies SpA , Immunetrics Inc., CATO SMS, and Evotec SE.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER